Stanza Digital Behavioral Therapy Shown to Address Fibromyalgia Patient Unmet Needs

By Nicole Villeneuve

Published November 30, 2023

This month, Swing Therapeutics presented data from a real-world trial of Stanza, an FDA-cleared digital behavioral therapy for treatment of fibromyalgia symptoms, at the 2023 annual meeting of  Association for Behavioral and Cognitive Therapies

The analysis of the ongoing trial data (108 patients) supports Stanza’s clinically meaningful benefit in addressing unmet needs for fibromyalgia patients, specifically, showing the treatment’s effectiveness on symptoms that most limit patient quality of life (QoL). 

After using the smartphone-based treatment, which provides Acceptance of Commitment Therapy and additional cognitive behavioral therapy-based interventions, 87% of participants improved in at least one QoL-limiting symptom. 3x patients reported QoL satisfaction after the treatment. 

Fibromyalgia (FM) is a chronic widespread pain syndrome that is often accompanied by additional symptoms. In this study, the top 5 most QoL-limiting symptoms identified by patients pre-treatment were (ranked by % patients reporting):

  1. Fatigue (76%)
  2. Cognitive function (62%)
  3. Pain interference (58%)
  4. Physical function (46%)
  5. Pain intensity (45%)

Improvement in each symptom at Stanza treatment at month 3 was assessed using the corresponding clinical measure(s) collected through: Patient Global Impression of Change (PGIC), Revised Fibromyalgia Impact Questionnaire (FIQ-R), Beck Depression Inventory (BDI-II), or Generalized Anxiety Disorder (GAD-7). 

The results showed most patients reduced their QoL-limiting symptoms with treatment, evidenced by high % of patients reporting improvement at month 3: 

  • 75% in sleep interference
  • 67% in cognitive function
  • 73% in pain interference
  • 87% in physical function
  • 54% in pain intensity

Swing Therapeutics also presented two additional studies at the same conference on its accumulated data from 3 clinical trials (2 RCTs and 1 real-world study), showing Stanza’s effectiveness in reducing fibromyalgia severity and improving sleep/fatigue outcomes.

How to Access Stanza: Stanza is offered by prescription through Swing Care, a clinic specializing in comprehensive, personalized treatment for fibromyalgia. Learn more about their approach to patient-centered care.


Related Posts


Swing Announces Positive Early Results from Specialty Fibromyalgia Clinic 

This week, Swing announced early outcomes from Swing Care, a specialty clinic dedicated to comprehensive, evidence-based fibromyalgia treatment. The results…

Read this Article >


Swing Therapeutics Announces Long-Term Effectiveness Data from Studies of Stanza

Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for chronic pain conditions, announced the publication of new research data…

Read this Article >